'Cost effectiveness analysis cea' diaporamas de présentation

Chapter 23 Pharmacoeconomic Calculations

Chapter 23 Pharmacoeconomic Calculations. Ellen S. Campbell, Ph.D. Associate Professor Division of Economic, Social & Administrative Pharmacy. Outline. Case Study Pharmacoeconomics defined PE Analyses Steps Perspectives Alternatives Examples of 4 types Sensitivity analysis Discounting

765 views • 51 slides

Chapter 23 Pharmacoeconomic Calculations

Chapter 23 Pharmacoeconomic Calculations. Ellen S. Campbell, Ph.D. Associate Professor Division of Economic, Social & Administrative Pharmacy. Outline. Case Study Pharmacoeconomics defined PE Analyses Steps Perspectives Alternatives Examples of 4 types Sensitivity analysis Discounting

660 views • 51 slides

LCDR Marisol Martinez, PharmD Fort Sam Houston, TX

A Peek at the PEC: An Overview of Formulary Management at the Department of Defense (DoD) TRICARE Management Activity (TMA) Pharmacoeconomic Center (PEC). LCDR Marisol Martinez, PharmD Fort Sam Houston, TX. Objectives.

657 views • 45 slides

WHAT IS HEALTH ECONOMICS?

397 views • 38 slides

Make Nutrition Services Count: Cost-Effectiveness Research & Outcomes Research

485 views • 35 slides

Cost Analysis in Social Work Research:

555 views • 34 slides

Cost-Benefit Analysis (CBA) Illustrated by the California GAIN Random Assignment Experiment

Cost-Benefit Analysis (CBA) Illustrated by the California GAIN Random Assignment Experiment. Plan of Discussion. What is Cost-Benefit Analysis? How is it done for social programs? What are some alternatives to CBA? How are the costs of social programs estimated (if time permits)?.

498 views • 33 slides

Phaedra Corso, Ph.D. Associate Professor College of Public Health University of Georgia

Program Evaluation from an Economic Perspective. Phaedra Corso, Ph.D. Associate Professor College of Public Health University of Georgia. Why Care About Economics in the Context of Prevention?. Maximizing outcomes is important. Minimizing costs is important too.

490 views • 33 slides

Phaedra Corso, Ph.D. Associate Professor College of Public Health University of Georgia

Program Evaluation from an Economic Perspective. Phaedra Corso, Ph.D. Associate Professor College of Public Health University of Georgia. Why Care About Economics in the Context of Prevention?. Maximizing outcomes is important. Minimizing costs is important too.

344 views • 33 slides

Drug and Therapeutics Committee

819 views • 32 slides

Drug and Therapeutics Committee

326 views • 32 slides

DIAC Session 2, November 18 2010 Policies and Programs

DIAC Session 2, November 18 2010 Policies and Programs. Professor Adam Graycar. The role of government in market economies. Facilitating Role Allocation Function Distribution Function Stabilisation Function. The role of government in market economies. 2. Facilitating Role

538 views • 31 slides

DIAC Session 2, November 18 2010 Policies and Programs

DIAC Session 2, November 18 2010 Policies and Programs. Professor Adam Graycar. The role of government in market economies. Facilitating Role Allocation Function Distribution Function Stabilisation Function. The role of government in market economies. 2. Facilitating Role

573 views • 31 slides

Health Economics

Health Economics. Chapter 14 : Efficiency and Cost Benefit Analysis. Cost-Benefit Analysis (CBA). CBA measures the benefits and costs of projects in money terms Problem: How to quantify years of life, improvements in health and well-being etc.

419 views • 25 slides

Pharmacoeconomics

Pharmacoeconomics. Presentation Developed for the Academy of Managed Care Pharmacy Updated: February 2016. Objectives. Define the term pharmacoeconomics Differentiate between the types of pharmacoeconomic evaluation methods

244 views • 20 slides